Annual Cash & Cash Equivalents
$28.21 M
-$4.70 M-14.27%
March 31, 2024
Summary
- As of February 7, 2025, MLAB annual cash & cash equivalents is $28.21 million, with the most recent change of -$4.70 million (-14.27%) on March 31, 2024.
- During the last 3 years, MLAB annual cash & cash equivalents has fallen by -$235.65 million (-89.31%).
- MLAB annual cash & cash equivalents is now -89.31% below its all-time high of $263.87 million, reached on March 31, 2021.
Performance
MLAB Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$30.96 M
+$6.62 M+27.20%
December 31, 2024
Summary
- As of February 7, 2025, MLAB quarterly cash and cash equivalents is $30.96 million, with the most recent change of +$6.62 million (+27.20%) on December 31, 2024.
- Over the past year, MLAB quarterly cash and cash equivalents has increased by +$2.48 million (+8.72%).
- MLAB quarterly cash and cash equivalents is now -88.88% below its all-time high of $278.29 million, reached on September 30, 2021.
Performance
MLAB Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MLAB Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.3% | +8.7% |
| 3 y3 years | -89.3% | -40.1% |
| 5 y5 years | +177.0% | -58.2% |
MLAB Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -89.3% | at low | -40.1% | +27.2% |
| 5 y | 5-year | -89.3% | +177.0% | -88.9% | +27.2% |
| alltime | all time | -89.3% | >+9999.0% | -88.9% | >+9999.0% |
Mesa Laboratories Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $30.96 M(+27.2%) |
| Sep 2024 | - | $24.34 M(-14.5%) |
| Jun 2024 | - | $28.47 M(+0.9%) |
| Mar 2024 | $28.21 M(-14.3%) | $28.21 M(-0.0%) |
| Dec 2023 | - | $28.22 M(-20.8%) |
| Sep 2023 | - | $35.62 M(+10.0%) |
| Jun 2023 | - | $32.38 M(-1.6%) |
| Mar 2023 | $32.91 M(-33.3%) | $32.91 M(+26.1%) |
| Dec 2022 | - | $26.10 M(-19.4%) |
| Sep 2022 | - | $32.38 M(-26.0%) |
| Jun 2022 | - | $43.75 M(-11.3%) |
| Mar 2022 | $49.35 M(-81.3%) | $49.35 M(-4.6%) |
| Dec 2021 | - | $51.71 M(-81.4%) |
| Sep 2021 | - | $278.29 M(+0.9%) |
| Jun 2021 | - | $275.71 M(+4.5%) |
| Mar 2021 | $263.87 M(+224.2%) | $263.87 M(+4.0%) |
| Dec 2020 | - | $253.73 M(+4.9%) |
| Sep 2020 | - | $241.92 M(+4.8%) |
| Jun 2020 | - | $230.95 M(+183.8%) |
| Mar 2020 | $81.38 M(+699.0%) | $81.38 M(+10.0%) |
| Dec 2019 | - | $73.98 M(-69.9%) |
| Sep 2019 | - | $245.44 M(+3255.3%) |
| Jun 2019 | - | $7.32 M(-28.2%) |
| Mar 2019 | $10.19 M(+86.2%) | $10.19 M(+77.8%) |
| Dec 2018 | - | $5.73 M(+1.8%) |
| Sep 2018 | - | $5.63 M(-24.0%) |
| Jun 2018 | - | $7.40 M(+35.3%) |
| Mar 2018 | $5.47 M(-6.0%) | $5.47 M(-6.4%) |
| Dec 2017 | - | $5.84 M(-43.1%) |
| Sep 2017 | - | $10.27 M(+245.0%) |
| Jun 2017 | - | $2.98 M(-48.9%) |
| Mar 2017 | $5.82 M(+2.2%) | $5.82 M(+7.7%) |
| Dec 2016 | - | $5.41 M(+6.6%) |
| Sep 2016 | - | $5.07 M(+9.3%) |
| Jun 2016 | - | $4.64 M(-18.6%) |
| Mar 2016 | $5.70 M(+180.0%) | $5.70 M(+74.1%) |
| Dec 2015 | - | $3.27 M(-40.1%) |
| Sep 2015 | - | $5.46 M(+177.4%) |
| Jun 2015 | - | $1.97 M(-3.2%) |
| Mar 2015 | $2.03 M(-63.5%) | $2.03 M(+42.5%) |
| Dec 2014 | - | $1.43 M(-61.0%) |
| Sep 2014 | - | $3.66 M(+14.3%) |
| Jun 2014 | - | $3.20 M(-42.6%) |
| Mar 2014 | $5.58 M(+39.2%) | $5.58 M(+158.1%) |
| Dec 2013 | - | $2.16 M(-36.9%) |
| Sep 2013 | - | $3.42 M(-4.6%) |
| Jun 2013 | - | $3.59 M(-10.4%) |
| Mar 2013 | $4.01 M(-44.3%) | $4.01 M(+47.2%) |
| Dec 2012 | - | $2.72 M(-1.8%) |
| Sep 2012 | - | $2.77 M(-39.6%) |
| Jun 2012 | - | $4.59 M(-36.1%) |
| Mar 2012 | $7.19 M(+102.8%) | $7.19 M(+26.4%) |
| Dec 2011 | - | $5.69 M(+14.9%) |
| Sep 2011 | - | $4.95 M(-18.2%) |
| Jun 2011 | - | $6.05 M(+70.7%) |
| Mar 2011 | $3.55 M(-66.1%) | $3.55 M(+66.6%) |
| Dec 2010 | - | $2.13 M(-40.4%) |
| Sep 2010 | - | $3.58 M(+40.7%) |
| Jun 2010 | - | $2.54 M(-75.7%) |
| Mar 2010 | $10.47 M(+14.9%) | $10.47 M(+5.3%) |
| Dec 2009 | - | $9.94 M(-11.5%) |
| Sep 2009 | - | $11.23 M(+4.4%) |
| Jun 2009 | - | $10.76 M(+18.1%) |
| Mar 2009 | $9.11 M(+57.9%) | $9.11 M(+14.4%) |
| Dec 2008 | - | $7.96 M(+18.3%) |
| Sep 2008 | - | $6.73 M(+5.3%) |
| Jun 2008 | - | $6.39 M(+10.7%) |
| Mar 2008 | $5.77 M(+72.4%) | $5.77 M(+11.3%) |
| Dec 2007 | - | $5.19 M(+9.8%) |
| Sep 2007 | - | $4.72 M(+20.9%) |
| Jun 2007 | - | $3.91 M(+16.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2007 | $3.35 M(-25.1%) | $3.35 M(+25.0%) |
| Dec 2006 | - | $2.68 M(-7.3%) |
| Sep 2006 | - | $2.89 M(-21.8%) |
| Jun 2006 | - | $3.69 M(-17.3%) |
| Mar 2006 | $4.47 M(-10.3%) | $4.47 M(+19.0%) |
| Dec 2005 | - | $3.75 M(-13.0%) |
| Sep 2005 | - | $4.32 M(-24.2%) |
| Jun 2005 | - | $5.70 M(+14.4%) |
| Mar 2005 | $4.98 M(+6.6%) | $4.98 M(+6.5%) |
| Dec 2004 | - | $4.67 M(-15.5%) |
| Sep 2004 | - | $5.53 M(+9.2%) |
| Jun 2004 | - | $5.07 M(+8.5%) |
| Mar 2004 | $4.67 M(-1.9%) | $4.67 M(-0.4%) |
| Dec 2003 | - | $4.69 M(-22.1%) |
| Sep 2003 | - | $6.02 M(+7.9%) |
| Jun 2003 | - | $5.58 M(+17.2%) |
| Mar 2003 | $4.76 M(+37.5%) | $4.76 M(+12.6%) |
| Dec 2002 | - | $4.23 M(-9.8%) |
| Sep 2002 | - | $4.68 M(+12.5%) |
| Jun 2002 | - | $4.16 M(+20.2%) |
| Mar 2002 | $3.46 M(+49.4%) | $3.46 M(+10.3%) |
| Dec 2001 | - | $3.14 M(+36.8%) |
| Sep 2001 | - | $2.29 M(+3.9%) |
| Jun 2001 | - | $2.21 M(-4.7%) |
| Mar 2001 | $2.32 M(-18.7%) | $2.32 M(-18.6%) |
| Dec 2000 | - | $2.85 M(+2.7%) |
| Sep 2000 | - | $2.77 M(-1.2%) |
| Jun 2000 | - | $2.81 M(-1.5%) |
| Mar 2000 | $2.85 M(-57.5%) | $2.85 M(+29.5%) |
| Dec 1999 | - | $2.20 M(-64.5%) |
| Sep 1999 | - | $6.20 M(-6.1%) |
| Jun 1999 | - | $6.60 M(-1.5%) |
| Mar 1999 | $6.70 M(+103.0%) | $6.70 M(+8.1%) |
| Dec 1998 | - | $6.20 M(+77.1%) |
| Sep 1998 | - | $3.50 M(-12.5%) |
| Jun 1998 | - | $4.00 M(+21.2%) |
| Mar 1998 | $3.30 M(-15.4%) | $3.30 M(-38.9%) |
| Dec 1997 | - | $5.40 M(+10.2%) |
| Sep 1997 | - | $4.90 M(+6.5%) |
| Jun 1997 | - | $4.60 M(+17.9%) |
| Mar 1997 | $3.90 M(+116.7%) | $3.90 M(+18.2%) |
| Dec 1996 | - | $3.30 M(+6.5%) |
| Sep 1996 | - | $3.10 M(+29.2%) |
| Jun 1996 | - | $2.40 M(+33.3%) |
| Mar 1996 | $1.80 M(+350.0%) | $1.80 M(+50.0%) |
| Dec 1995 | - | $1.20 M(+33.3%) |
| Sep 1995 | - | $900.00 K(0.0%) |
| Jun 1995 | - | $900.00 K(+125.0%) |
| Mar 1995 | $400.00 K(-55.6%) | $400.00 K(-60.0%) |
| Dec 1994 | - | $1.00 M(-9.1%) |
| Sep 1994 | - | $1.10 M(0.0%) |
| Jun 1994 | - | $1.10 M(+22.2%) |
| Mar 1994 | $900.00 K(+800.0%) | $900.00 K(+80.0%) |
| Dec 1993 | - | $500.00 K(+25.0%) |
| Sep 1993 | - | $400.00 K(+33.3%) |
| Jun 1993 | - | $300.00 K(+200.0%) |
| Mar 1993 | $100.00 K(-93.8%) | $100.00 K(-95.0%) |
| Dec 1992 | - | $2.00 M(+11.1%) |
| Sep 1992 | - | $1.80 M(0.0%) |
| Jun 1992 | - | $1.80 M(+12.5%) |
| Mar 1992 | $1.60 M(+60.0%) | $1.60 M(+23.1%) |
| Dec 1991 | - | $1.30 M(+18.2%) |
| Sep 1991 | - | $1.10 M(+22.2%) |
| Jun 1991 | - | $900.00 K(-10.0%) |
| Mar 1991 | $1.00 M(+150.0%) | $1.00 M(+66.7%) |
| Dec 1990 | - | $600.00 K(0.0%) |
| Sep 1990 | - | $600.00 K(+20.0%) |
| Jun 1990 | - | $500.00 K(+25.0%) |
| Mar 1990 | $400.00 K(-50.0%) | $400.00 K(+100.0%) |
| Dec 1989 | - | $200.00 K(-75.0%) |
| Mar 1989 | $800.00 K(0.0%) | $800.00 K(0.0%) |
| Mar 1988 | $800.00 K | $800.00 K |
FAQ
- What is Mesa Laboratories annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Mesa Laboratories?
- What is Mesa Laboratories annual cash & cash equivalents year-on-year change?
- What is Mesa Laboratories quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Mesa Laboratories?
- What is Mesa Laboratories quarterly cash and cash equivalents year-on-year change?
What is Mesa Laboratories annual cash & cash equivalents?
The current annual cash & cash equivalents of MLAB is $28.21 M
What is the all time high annual cash & cash equivalents for Mesa Laboratories?
Mesa Laboratories all-time high annual cash & cash equivalents is $263.87 M
What is Mesa Laboratories annual cash & cash equivalents year-on-year change?
Over the past year, MLAB annual cash & cash equivalents has changed by -$4.70 M (-14.27%)
What is Mesa Laboratories quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MLAB is $30.96 M
What is the all time high quarterly cash and cash equivalents for Mesa Laboratories?
Mesa Laboratories all-time high quarterly cash and cash equivalents is $278.29 M
What is Mesa Laboratories quarterly cash and cash equivalents year-on-year change?
Over the past year, MLAB quarterly cash and cash equivalents has changed by +$2.48 M (+8.72%)